Cannabis y Parkinson, otro estudio que avala sus cualidades terapéuticas
disease/jpd202260" title="" target="_blank">The study was published in the Journal of Parkinson"s Disease and conducted by researchers from the Hamburg-Eppendorf University Medical Center. The survey was conducted with 1,300 Parkinson"s patients with the aim of evaluating the percentage of users, the frequency of use, and the attitudes of doctors and patients regarding consumption, or possible future use.
The results showed that 8% of those surveyed had used cannabis and more than half claimed to feel improvement when doing so. Also that of the percentage who had not used cannabis, 65% were interested in doing so. The reason they had not done so was the lack of information about it.
Other figures that emerged from the study were that only 9% of those surveyed knew the difference between THC and CBD. It is somewhat surprising because Parkinson"s sufferers meet the national criteria for the use of medicinal cannabis. Dr Carsten Buhmann from the Department of Neurology at the Hamburg-Eppendorf University Medical Center commented that "There is little data on what type of cannabinoid and what route of administration could be promising for which patient and what symptoms. "
He also commented that "Clinicians should consider these issues when counseling their patients on medical cannabis treatment. The data reported here can help clinicians decide which patients might benefit, what symptoms might be addressed, and what type of cannabinoid and pathway administration might be adequate. "
In general, the study found that there is great interest, on the part of physicians and patients, in cannabis treatments, but there is still much ignorance about it. We hope this will change over time and encourage further studies to advance cannabic treatments.
